INTERNATIONAL PATENT: MEDIFAB CO., LTD., 주식회사 메디팹 FILES APPLICATION FOR "COMPOSITION COMPRISING CHITOSAN DERIVATIVE AND DECELLULARIZED EXTRACELLULAR MATRIX HYDROLYSATE AND USE THEREOF"

GENEVA, May 19 -- MEDIFAB CO., LTD. (Rm.417, 5 Gasan digital 1-ro,Geumcheon-gu,Seoul 08594), 주식회사 메디팹 (서울특별시금천구가산디지털1로 5, 417호) filed a patent application (PCT/KR2024/017783) for "COMPOSITION COMPRISING CHITOSAN DERIVATIVE AND DECELLULARIZED EXTRACELLULAR MATRIX HYDROLYSATE AND USE THEREOF" on Nov 11, 2024. With publication no. WO/2025/101033, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (...